Form4insider filings, from the source

SEC Form 4 · accession 0000911916-17-000042

ZIMMER BIOMET HOLDINGS, INC. · ZBH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Katarzyna Mazur-Hofsaess
Officer — Pres., Eur., M. East & Afr.
Period of report
Feb 2, 2017
Accepted (ET)
Feb 6, 2017 · 4:21 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001136869

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockFeb 2, 2017M2,390$60.01A14,387D
Common StockFeb 2, 2017M11,312$64.13A25,699D
Common StockFeb 2, 2017M17,530$73.15A43,229D
Common StockFeb 2, 2017M12,963$94.34A56,192D
Common StockFeb 2, 2017S44,195$118.00D11,997D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (right to buy)F1$60.01Feb 2, 2017M2,390D—Mar 16, 2021Common Stock2,3900D
Employee Stock Option (right to buy)F2$64.13Feb 2, 2017M11,312D—Mar 19, 2022Common Stock11,3120D
Employee Stock Option (right to buy)F3$73.15Feb 2, 2017M17,530D—Mar 18, 2023Common Stock17,5308,765D
Employee Stock Option (right to buy)F4$94.34Feb 2, 2017M12,963D—Mar 17, 2024Common Stock12,96312,962D

Explanation of responses